Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026Cancer Immunology Research

FasL-mediated death of activated intratumoral T cells drives secondary resistance to cancer immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

QCQing ChenEGEhsan GhoraniKFKane Foster

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/6aabb7e75f706d05830e743dhttps://doi.org/10.1158/2326-6066.cir-25-1567
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Treg-cell death axis in lung cancer: implications for immune evasion and novel therapeutic strategies2026
  2. 2T <sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I–deficient metastatic pancreatic cancer2026
  3. 3Tumor-targeted therapy with BRAF-inhibitor recruits activated dendritic cells to promote tumor immunity in melanoma2024 · 10 citations
  4. 4CD8+ T cell-derived Fgl2 regulates immunity in a cell-autonomous manner via ligation of FcγRIIB2024 · 5 citations
  5. 5A Glucocorticoid-Fas axis controls immune evasion from pan-cytotoxic lymphocytes during metastatic seeding 23341932026